Implementation of a “seamless” model of providing specialized medical care to patients with heart failure

Мұқаба

Дәйексөз келтіру

Толық мәтін

Аннотация

Heart failure (HF) is a widespread disease and tends to increase. Despite the possibilities of modern therapy, the prognosis of patients with HF remains unfavorable. Foreign experience shows that the creation of specialized heart failure clinics improves the quality of care for patients with HF, reduces the frequency of repeated hospitalizations and death of patients. The Russian Federation has gained experience in creating such clinics, in particular, in Nizhny Novgorod, Ufa, St. Petersburg and a number of other cities. The article describes the organization of the work of the Center for HF on the basis of a multidisciplinary hospital in Moscow in period 01.11.2020-01.12.2022. The database included 2,400 patients hospitalized due to acute decompensation of chronic HF (ADCHF). The leading triggers of ADCHF in the studied patient population were an episode of atrial fibrillation/flutter (37 %), low adherence to treatment (25 %) and uncontrolled hypertension (17 %), exacerbation of concomitant diseases (11 %), infection (4 %). In 6 % of patients, the leading trigger could not be identified. The hospital stage included 950 (39.5 %) patients who, in the first 24 hours from the moment of hospitalization, underwent standard physical, laboratory and instrumental examination, including lung ultrasound, NT-proBNP, liver fibroelastometry, VEXUS protocol study, bioimpedance analysis of body composition, of which 496 (20.5 %) people passed the same studies at discharge. In the structure of patients hospitalized with ADCHF who were included in the hospital follow-up stage (n=950), patients with preserved (HFpEF) 42.5 % (n=404) and reduced ejection fraction (HFrEF) prevailed 36 % (n=342), patients with a mildly reduced (HFmrEF) ejection fraction were found in 21.5 %. 1,552 (64.5 %) patients refused additional studies and visits to the CH center, but agreed to outpatient follow-up in the form of telephone contacts. In 370 (15.4 %) patients, contact was lost after discharge. 240 (10 %) patients actively visit the HF center with a comprehensive assessment of congestion and correction of therapy at each visit. Conclusion. There are two stages in the treatment of patients with chronic HF. The first stage is hospital, the second one is outpatient. It is important not to make omissions in the prescribed drug therapy, which can lead to a fatal outcome. To this end, it is necessary to introduce a “seamless” model of medical care for patients with chronic HF, when the patient comes under the supervision of a multidisciplinary team that carries out timely monitoring.

Негізгі сөздер

Авторлар туралы

Zhanna Kobalava

City Clinical Hospital named after V.V. Vinogradov; RUDN University

Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0002-5873-1768
SPIN-код: 9828-5409
Moscow, Russian Federation

Veronica Tolkacheva

RUDN University

Хат алмасуға жауапты Автор.
Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0001-6847-8797
SPIN-код: 2282-2127
Moscow, Russian Federation

Maria Vatsik-Gorodetskaya

City Clinical Hospital named after V.V. Vinogradov

Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0002-6874-8213
SPIN-код: 5531-0698
Moscow, Russian Federation

Flora Cabello-Montoya

RUDN University

Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0002-2334-6675
Moscow, Russian Federation

Ivan Nazarov

RUDN University

Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0002-0950-7487
Moscow, Russian Federation

Svyatoslav Galochkin

City Clinical Hospital named after V.V. Vinogradov; RUDN University

Email: tolkacheva-vv@rudn.ru
ORCID iD: 0000-0001-7370-8606
SPIN-код: 9396-6834
Moscow, Russian Federation

Әдебиет тізімі

  1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020;141(9): e139-e596. doi: 10.1161/CIR.0000000000000757.
  2. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC; OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296(18):2217-2226. doi: 10.1001/jama.296.18.2217.
  3. Roger VL, Weston SA, Redfield MM, Hellermann-­Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-­based population. JAMA. 2004;292(3):344-50. doi: 10.1001/jama.292.3.344.
  4. Arutyunov AG. ACE Inhibitors in CHF: Necessity despite the Change of Goals. Trydnya patient. 2014;12(5):31-35. [In Russian].
  5. Villevalde SV, Kobalava ZhD, Solovyeva AЕ, Moiseev VS. The concurrence of kidney and liver dysfunctions in decompensated heart failure. Terapeuticheskiy archive. 2016;88 (6):40-44. doi: 10.17116/terarkh201688640-44. [In Russian].
  6. Belenkov YuN, Mareev VYu, Ageev FT, Fomin IV, Badin YuV, Polyakov DS, Danielyan MO, Artemeva EG, Malenkova VYu, Poroshina EA, Tarlovskaya EI, Smirnova EA, Yakushin SS, Sherbinina EV. The true prevalence of CHF in the European part of the Russian Federation (hospital stage). Zhurnal serdechnaya nedostatochnost. 2011;12(2):63-8 [In Russian].
  7. Arisheva O, Garmash I, Sarlykov B. The prevalence and prognostic significance of liver disease in chronic heart failure. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther 2021;30(1):70-74 (In Russian). doi 10.32756/ 0869-5490-2021-1-70-74.
  8. Borisova MV. Acute Decompensation of Heart Failure: frequency and risk factors of repeated hospitalization. Zhurnal meditsina I obrazovanie v Sibiri. 2013;2. [In Russian]. http//www.ngmu.ru/cozo/mos/article/text_full.php?id=979 Access date 14.03.2023.
  9. Zarudsky AV, Perutskaya EA. Preventing decompensation of chronic heart failure. Meditsinskaya sestra. 2016;4:20-22. [In Russian].
  10. Lund L, Claggett B, Liu J, Lam C, Jhund P, Rosano G, Swedberg K, Yusuf S, Granger C, Pfeffer M, McMurray J, Solomon S. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Eur J Heart Fail. 2018;20(8):1230-1239.
  11. Fomin I, Belenkov Yu, Mareev V, Ageev F, Badin Yu, Galyavich A, Danielyan M, Kamalov G, Kolbin A, Kechedgieva C, Makarova V, Makarova N, Malnekova V, Saifutdinov P, Tarlovskaya E, Khokhlov P, Sherbinina E, Yakushin C. The prevalence of chronic heart failure in the European part of the Russian Federation (part 2) - EHPOHA-HSN. Zhurnal serdechnaya nedostatochnost 2006;7(37):112-5. [In Russian].
  12. Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T on behalf of the ATTEND Investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry). Circulation journal. 2013;77(4):944-951.
  13. Kositsyna I, Tereshchenko S, Uskach T, Golubev A, Nasonova C, Zhirov I. New opportunities in acute decompensated heart failure treatment. Kardiologicheskiy vestnik. 2014;9(2):68-74. [In Russian].
  14. Savina NM, Senichkina AA. Acute decompensation of cardiac insufficiency. Modern state-of-art. Kremlevskaya meditsina. Klinicheskiy vestnik. 2017;2:107-121. (In Russian).
  15. Tereschenko SN, Zhirov IV, Nasonova SN, Nikolaeva OA, Ledyakhova MV. Acute Decompensated Heart Failure: What We Know in 2016. Lechebnoye delo. 2016;2:4-13. [In Russian].
  16. Batyushin MM, Vachugova AA, Gilyarevskiy SR, Dzherieva IS, Zakaryaeva NA, Zykov MV, Ivanenko VV, Isaeva US, Kanorskiy SG, Kiseleva MA, Kurbanova IM, Lopatin YM, Nedogoda SV, Saneeva GA, Slavickaya ES, Khadartceva EL. Findings from the EMPEROR-Reduced study are a tool to improve care for patients with chronic heart failure with reduced ejection fraction. Resolution of the Regional Scientific Meeting of Experts of the Southern Federal District. South Russian Journal of Therapeutic Practice. 2021;2 (2):104-110. https://doi.org/10.21886/2712-8156-2021-2-2-104-110. [In Russian].
  17. Kosiborod M, Lichtman J, Heidenreich P, Normand S, Wang Y, Brass L, Kromholz H. National trends in outcomes among elderly patients with heart failure. The American journal of medicine. 2006;119(7):616.e1-616.e7. doi: 10.1016/j.amjmed.2005.11.019.
  18. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA. Decision making in advanced heart failure: A scientific statement from the American heart association. Circulation. 2012;125(15):1928-52. doi: 10.1161/CIR.0b013e31824f2173.
  19. Hollenberg S, Warner Stevenson L, Ahmad T, Amin V, Bozkurt B, Butler J, Davis L, Drazner M, Kirkpatrick J, Peterson P, Reed B, Roy C, Storrow A. 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019;74(15):1966-2011. doi: 10.1016/j.jacc.2019.08.001.
  20. Ambrosy A, Pang P, Khan S, Kostan M, Fonarow G, Traver B, Maggioni A, Cook T, Swedberg K, Burnett J, Grinfeld L, Uldelson J, Zannad F, Gheorghiade M.; EVEREST Trial Investigators. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34(11):835-43. doi: 10.1093/eurheartj/ehs444.
  21. Kobalava ZD, Safarova AF, Soloveva AE, Cabello FE, Meray IA, Shavarova EK, Villevalde SV. Pulmonary Congestion Assessed by Lung Ultrasound in Decompensated Heart Failure. Kardiologiia. 2019;59(8):5-14. (In Russian). https://doi.org/10.18087/cardio.2019.8.n534.
  22. Alvarez-­Garcia J, Rivas-­Lasarte M, Benedicto A, Martinez J, Lopez L, Perez S, Brossa V, Mesado N, Pirla M, Cinca J, Roig E, Green A. Subclinical Pulmonary Congestion: A Silent And Prevalent Killer At Heart Failure Discharge. J Am Coll Cardiol. 2020;75(11):1093. doi: 10.1016/s0735-1097(20)31720-4.
  23. Rubio-­Gracia J, Demissei B, ter Maaten J, Cleland J, O’Connor C, Metra M, Ponikowski P, Teerlink J, Cotter G, Davison B, Givertz M, Bloomfield D, Dittrich H, Damman K, Pérez-­Calvo J, Voors A. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018; 258:185-91. doi: 10.1016/j.ijcard.2018.01.067.
  24. Pellicori P, Kaur K, Clark AL. Fluid management in patients with chronic heart failure. Card Fail Rev. 2015;1:90-5. doi: 10.15420/cfr.2015.1.2.90.
  25. Maisel AS, Duran JM, Wettersten N. Natriuretic peptides in heart failure: atrial and B-type natriuretic peptides. Heart Fail Clin. 2018;14:13-25. doi: 10.1016/j.hfc.2017.08.002.
  26. Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. European journal of heart failure. 2015;17(10):1172-1181.
  27. Platz E, Lewis E, Uno H, Peck J, Pivetta E, Merz A, Hempel D, Wilson C, Frasure S, Jhund P, Cheng S, Solomon S. Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. European Heart Journal. 2016;37 (15):1244-1251. doi: 10.1093/eurheartj/ehv745.
  28. Platz E, Campbell R, Claggett B, Lewis E, Groarke J, Docherty K, Lee M, Merz A, Silverman M, Swamy V, Lindner M, Rivero J, Solomon S, McMurray J. Lung ultrasound in acute heart failure: Prevalence of pulmonary congestion and short- and long-term outcomes. JACC Heart Fail. 2019;7(10):849-858. doi: 10.1016/j.jchf.2019.07.008.
  29. Bandyopadhyay D, Ashish K, Dhaduk K, Banerjee U, Banerjee U, Mondal S, Herzog E. Role of liver stiffness in prediction of adverse outcomes in heart failure. Journal of Cardiology. 2019;73(2):185-186.
  30. Beaubien-­Souligny W, Rola P, Haycock K, Bouchard J, Lamarche Y, Spiegel R, Denault A. Quantifying systemic congestion with Point-­Of-­Care ultrasound: development of the venous excess ultrasound grading system. The ultrasound journal. 2020;12(16). https://doi.org/10.1186/s13089-020-00163.
  31. Beaubien-­Souligny W, Eljaiek R, Fortier A, Lamarche Y, Liszkowski M, Bouchard J, Denault A. The association between pulsatile portal flow and acute kidney injury after cardiac surgery: a retrospective cohort study. J Cardiothorac Vasc Anesth. 2018;32 (4):1780-1787.
  32. Tang W, Kitai T. Intrarenal Venous Flow: A Window into the Congestive Kidney Failure Phenotype of Heart Failure? JACC Heart failure. 2016;4 (8):683-686.
  33. Massari F, Iacoviello M, Scicchitano P, Mastopasqua F, Guida P, Riccioni G, Speziale G, Caldarola P, Ciccone M, Somma S. Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure. Heart Lung. 2016;45 (4):319-26. doi: 10.1016/j.hrtlng.2016.03.008.
  34. Somma S, Lalle I, Magrini L, Russo V, Navarin S, Castello L, Avanzi G, Stasio A, Maisel A. Additive diagnostic and prognostic value of Bioelectrical Impedance Vector Analysis (BIVA) to brain natriuretic peptide ‘grey-zone’ in patients with acute heart failure in the emergency department. European Heart Journal Acute Cardiovascular Care. 2014;3 (2):167-175. doi: 10.1177/2048872614521756.
  35. Piccoli A. Bioeletric impedance vector distribution in peritoneal dialysis patient with different hydration status. Kidney International. 2004;65(3):1050-1063.
  36. Santarelli S, Russo V, Lalle I, Berardinis B, Vetrone F, Magrini L, Stasio E, Piccoli A, Codognotto M, Mion M, Castello L, Avanzi G, Somma S; GREAT network. Prognostic value of decreased peripheral congestion detected by bioelectrical impedance vector analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. European Heart Journal Acute Cardiovasc Care. 2017;6 (4):339-347. doi: 10.1177/2048872616641281.
  37. Argaiz ER, Koratala A, Reisinger N. Comprehensive Assessment of Fluid Status by Point-of-­Care Ultrasonography. KIDNEY360. 2021;2:1326-1338, doi: https://doi.org/10.34067/KID.0006482020.
  38. Drapkina OM, Dzhioeva ON, Balakhonova TV, Safarova AF, Ershova AI, Zorya OT, Pisaryuk AS, Kobalava Zh D. Ultrasound-­assisted examination in internal medicine practice. Guidelines. Cardiovascular Therapy and Prevention. 2023;22(1):3523. doi: 10.15829/1728-8800-2023-3523.
  39. Van Spall H, Rahman T, Mytton O, Ramasundarahettige C, Ibrahim C, Kabali C, Coppens M, Haynes R, Connolly S. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis. Eur J Heart Fail. 2017; 19:1427-1443. doi: 10.1002/ejhf.765.
  40. Jonkman N, Westland H, Groenwold R, Agren S, Anguita M, Blue L, Bruggink-­Andrede la Porta P, DeWalt D, Hebert P, Heisler M, Jaarsma T, Kempen G, Leventhal M, Lok D, Martensson J, Muniz J, Otsu H, Peters-­Klimm F, Rich M, Riegel B, Stromberg A, Tsuyuli R, Trappenburg J, Schuurmans M, Hoes A. What are effective program characteristics of self-management interventions in patients with heart failure? An individual patient. data meta-analysis. J Card Fail. 2016; 22:861-871. doi: 10.1016/j.cardfail.2016.06.422.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».